Inventera Inc. (KOSDAQ:0007J0)

Market Cap	68.82B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,664
Open	9,180.00
Previous Close	9,190.00
Day's Range	8,550.00 - 9,190.00
52-Week Range	6,090.00 - 60,200.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Inventera

Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 0007J0

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error